Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain.
At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
The Director of Global Clinical Operations will manage a team of clinical professionals and is responsible for all aspects of clinical operations, including site qualification and initiation, clinical trial agreements, patient enrollment, oversight of adverse event reporting, safety responsibilities, monitoring, adherence to protocols and determining study completion for studies conducted worldwide. The Director of Clinical Operations will also be responsible for the development of budgets, and work with management when input is necessary. Travel requirement is approximately 30%.